- Hybridoma cell lines producing antibodies to RSV NS1
Ref: E-167-2018-0 | Updated: Oct 18, 2018 | NIAID
- Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP as an Intranasal Ebola Vaccine...
Ref: E-142-2018-0 | Updated: Oct 9, 2018 | NIAID
Diagnostics, Antibodies, Antigens
- Protein Nanoparticles for Antigen Display in Vaccines
Ref: E-005-2017-0 | Updated: Mar 9, 2018 | NIAID
- Recombinant RSV B1 expressing eGFP as a reporter gene
Ref: E-159-2018-0 | Updated: Oct 9, 2018 | NIAID
- Mononegavirales Vectors expressing Chimeric Antigens
Ref: E-018-2018-0 | Updated: May 7, 2018 | NIAID
- Synergistic Internal Ribosomal Entry Site (IRES)—MicroRNA-Based Approach for Attenuation of Flaviviruses and Live...
Ref: E-006-2017/0 | Updated: Mar 1, 2017 | NIAID
- Glycan-masked engineered outer domains of HIV-1 GP120 and Their Use
Ref: E-083-2017-0 | Updated: Oct 12, 2018 | NIAID